Global and China Biopharmaceutical Industry Report
2010
In recent years, biopharmaceutical industry has been the fastest growing sector in the global pharmaceutical industry. From 1998 to 2009, the compound annual growth rate of biopharmaceutical industry reached 18.6%,... |
Nanotechnology in Health Care
US Industry Study with Forecasts to 2011, 2016 & 2021
US demand to grow 17.5% annually through 2011
US demand for nanotechnology medical products will increase over 17 percent per year to $53 billion in 2011. Afterwards, the increasing flow... |
Preclinical Development of Monoclonal Antibodies and Related Biologicals
Emerging Technologies and New Therapeutic Candidates
Monoclonal antibodies form the fastest growing segment of the pharmaceutical industry, with total annual sales expected to top $50 billion in the next four years. 23 full-size monoclonal antibodies and... |
Monoclonal Antibody Therapeutics 2009-2024
Monoclonal Antibody Therapeutics 2009-2024 - market growth, novel technologies and expansion into new therapeutic areas - our new report examines the significant commercial opportunities
Monoclonal antibodies achieved total sales of nearly... |
Monoclonal Antibody Based Products
Global Trends
Monoclonal antibodies represent one of the successes of the biotechnology industry along with a broad range of therapeutics and diagnostics. Monoclonal Antibody (MAb)-based products market is one of the fastest... |
Biotechnologies for Medical Applications
Global Markets
This Report Contains
An overview of biotechnologies used in medical applications, including amino acids, monoclonals, stem cells, botanicals, vaccines, recombinant DNA, and nanobiotechnology
Analysis of market trends, with data for 2009, estimates... |
Dynamic Antibody Industry
Monoclonal antibody drugs offer several advantages over other types of drugs. Technologically, antibodies exhibit amazing specificity that allows for a safe and targeted attack on disease-causing cells or compounds. The... |
Monoclonal Antibody Based Products
This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$. The major product segments and application areas analyzed are Therapeutics, and Diagnostics, especially for cancer.... |
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. Targeted biologics utilizing monoclonal antibody (mAb)-based technologies have rapidly developed... |
Monoclonal Antibodies
2010
Across the branded prescription pharmaceutical market monoclonal antibodies (MAbs) are forecast to be the strongest performing molecule type, delivering a forecast six year compound annual growth rate of 9.5% over... |
U.S. and Worldwide Monoclonal Antibody Medicine
Current Status and Future Trends
Antibody drugs were a $24 billion business in 2007. Although most pharmaceuticals are chemically synthesized small molecules, antibodies are large and complex proteins (immunoglobulins) that act as the human body's... |
Immunochemicals
This report analyzes the worldwide markets for Immunochemicals in US$ million by the following product segments - Catalog Antibodies, and Custom Antibodies. The report provides separate comprehensive analytics for the... |
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
Report overview
The success of protein and peptide therapeutics is revolutionizing the biotech and pharmaceutical market, spurring the creation of next-generation products with reduced immunogenicity, improved safety and greater effectiveness. New... |
Global Protein Therapeutics Market, The
Market Dynamics and Pipeline Analysis
The global protein therapeutics market was valued at US$57 billion in 2005. Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products... |
World Respiratory Disorders Market 2009-2024
Expanding patent populations and rising disease prevalence - World Respiratory Disorders Market 2009-2024 shows you where the opportunities lie in respiratory disorders
Respiratory disorder therapies form an important and competitive part... |
Biologic Therapeutic Drugs
Technologies and Global Markets
A comprehensive analysis of biologics, or biopharmaceuticals, on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry... |
Chinese Markets for Monoclonal Antibody
China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new... |
The Future of the Biologicals Market
Market overview, innovations and company profiles
Biopharmaceutical products are the key to the future of the pharmaceutical market. Even before the market stagnation seen in 2009 due to the recession, conventional pharmaceuticals were facing drastic consequences... |
Monoclonal Antibodies 2007
Competitive Landscape & Pipeline Insight
In 2005, the antibodies market was valued at an estimated US$14 billion, accounting for over 24 percent of the total protein therapeutics market. This share increased substantially since 2001, when... |
Monoclonal Antibody Therapies 2004
Entering A New Competitive Era
This new report has been written to provide members of the pharmaceutical, biotech, and venture capital industries an analytically-based overview of the market for therapeutic monoclonal antibodies (MAbs).
The market for... |
Immunotherapy of Cancer
Cancer immunotherapeutics, in particular monoclonal antibody-based products and vaccines, are transforming the cancer treatment market and providing a whole new arsenal of weapons. The introduction of the first monoclonal antibody... |
World Biological Drugs Market
2011-2021
Do you want to find market prospects for products and companies in the biological drugs industry? Our new report shows you biopharma revenue forecasts for 2011 to 2021. We provide... |
Development and Commercialisation of Protein Therapeutics
Technologies, pipelines and forecasts
With a combined annual market valued at $33 billion annually, the market for protein therapeutics encompasses several major drug classes and disease indications ranging from infectious disease, cancer indications, inflammatory... |
Antibody Technology Companies 2010
A systematic guide through the landscape of antibody technologies and their providers
The report "Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers" provides a description and assessment of antibody technologies and their corporate... |
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Drug delivery is evolving at a rapid rate with new drug product formulations being discovered frequently. Advanced drug delivery deals with developing solutions for new entities in therapeutic pharmacology such... |
Monoclonal Antibodies in Cancer Therapy
World Market Prospects 2010-2025
In 2009, monoclonal antibodies for cancer therapy generated total
revenues of over $18bn worldwide. From 2010, that sector will benefit
from new drugs and expanding indications for existing products. Cancer
incidence and prevalence... |
Global Monoclonal Antibody Market Analysis
Considered as an indispensable tool in the clinical and biotechnology sector, monoclonal antibodies have testified to be useful in the diagnosis and treatment of many infectious, immune, and neoplastic diseases... |
The Future of Monoclonal Antibodies
Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
GBI Research, the leading business intelligence provider, has released its latest research "The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis." The... |
Biosimilars and Follow-On Biologics
World Market 2011-2021
How will the biosimilars and follow-on biologics market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021.This report covers drugs... |
Preclinical Cancer Therapeutics 2007
Decoding Next Generation Drug Targets for Market Success
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success is a unique and unrivalled 367-page report analysing the performance of numerous important early stage oncology drug candidates,... |
Therapeutic Monoclonal Antibodies Markets
Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein... |
